Drug Trial Radar · NCT07201051
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
363
Planned (sponsor's estimate)
Start
Oct 30, 2025
Primary completion
May 4, 2027
Study completion Dec 10, 2027
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Oct 1, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to find out how effective and safe a new drug, GSK3862995B, is for adult participants with bronchiectasis, a chronic lung disease. The study will also test how the body processes the drug and to check for any immune reactions. Participants will be divided into groups randomly to receive either one of two different doses of the study drug or a placebo. The main goal of the study is to see how well the drug works compared to the placebo in helping those with bronchiectasis.
Conditions
- Bronchiectasis
Interventions
GSK3862995BDrug
Participants will be administered with dose level 1 of GSK3862995B.
PlaceboDrug
Participants will be administered with matching placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized rate of Exacerbations for GSK3862995B Dose Level 1 Following Repeat Doses Compared with PlaceboTime frame: Up to Week 48
Locations
134 sites in 12 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Mobile, Alabama · Recruiting
GSK Investigational Site
Phoenix, Arizona · Recruiting
GSK Investigational Site
La Palma, California · Recruiting
GSK Investigational Site
Valencia, California · Recruiting
GSK Investigational Site
Aurora, Colorado · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Naples, Florida · Recruiting
GSK Investigational Site
Pembroke Pines, Florida · Recruiting
GSK Investigational Site
Plantation, Florida · Recruiting
GSK Investigational Site
St. Petersburg, Florida · Recruiting
GSK Investigational Site
Tamarac, Florida · Recruiting
GSK Investigational Site
Winter Park, Florida · Recruiting
GSK Investigational Site
Hammond, Indiana · Recruiting
GSK Investigational Site
New Orleans, Louisiana · Recruiting
GSK Investigational Site
Rockville, Maryland · Recruiting
GSK Investigational Site
St Louis, Missouri · Recruiting
GSK Investigational Site
Henderson, Nevada · Recruiting
GSK Investigational Site
New Hyde Park, New York · Recruiting
GSK Investigational Site
Winston-Salem, North Carolina · Recruiting
GSK Investigational Site
DuBois, Pennsylvania · Recruiting
GSK Investigational Site
Anderson, South Carolina · Recruiting
GSK Investigational Site
Rock Hill, South Carolina · Recruiting
GSK Investigational Site
Spartanburg, South Carolina · Recruiting
GSK Investigational Site
Union, South Carolina · Recruiting
GSK Investigational Site
Franklin, Tennessee · Recruiting
GSK Investigational Site
Knoxville, Tennessee · Recruiting
GSK Investigational Site
Conroe, Texas · Recruiting
GSK Investigational Site
Cypress, Texas · Recruiting
GSK Investigational Site
Sugar Land, Texas · Recruiting
GSK Investigational Site
Williamsburg, Virginia · Recruiting
GSK Investigational Site
Buenos Aires, Argentina · Recruiting
GSK Investigational Site
CABA, Argentina · Recruiting
GSK Investigational Site
CABA, Argentina · Recruiting
GSK Investigational Site
Rosario Provincia de Santa FE, Argentina · Recruiting
GSK Investigational Site
San Miguel de Tucumán, Argentina · Recruiting
GSK Investigational Site
San Miguel de Tucumán, Argentina · Recruiting
GSK Investigational Site
San Miguel de Tucumán, Argentina · Recruiting
GSK Investigational Site
Santa Fe, Argentina · Recruiting
GSK Investigational Site
Beijing, China · Recruiting
Showing 40 of 134 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.